Corona vaccine approval boosts price

Labor technician bei Valneva

The French company has been searching for a dead vaccine against the corona virus for a long time.

(Photo: AP)

Frankfurt The share price of Franco-Austrian biotechnology company Valneva rose by double digits on Thursday. Late Thursday afternoon, after trading resumed, which had been suspended in the meantime, it was 20% higher at the start of the day at more than 20 euros.

The trigger for this is that the British Medicines Agency has approved the Covid 19 vaccine developed by Valnea. Britain is the first country in Europe to approve the vaccine. According to this, adults between the ages of 18 and 50 will in future be able to receive the inactivated corona virus vaccine.

The vaccine is based on a process widely used in the manufacture of influenza and polio vaccines and is easier to store than mRNA vaccines. Valneva hopes the European Medicines Agency (EMA) will also grant approval in April. The EU has already ordered 60 million doses of the vaccine, dubbed VLA2001.

Keep reading now

Access this article and all other articles in the

Web and in our app for free for 4 weeks.

Continue

Keep reading now

Access this article and all other articles in the

Web and in our app for free for 4 weeks.

Continue

Leave a Comment